Vallon Pharmaceuticals Inc

NASDAQ:VLON

5.35

+0.56 (+11.69%)

4:56:14 PM EDT: $5.41 +0.06 (+1.12%)

Vallon Pharmaceuticals Inc Stock, NASDAQ:VLON

Two Logan Square, 100 North 18th Street, Philadelphia, Pennsylvania 19103

United States of America

Phone: +1.267.207.3606

Number of Employees: 2

http://www.vallon-pharma.com

Description

Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA.